2023-10-31T19:54:17
Italy-based Alfasigma has agreed to acquire the Jyseleca (filgotinib) business from Belgian biotech Galapagos for €170 million.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-09-24T15:24:00
Sponsored by Lonza
2025-09-19T15:46:00
Sponsored by ACCI, By European Pharmaceutical Review
2025-06-26T08:43:00
Sponsored by Uniphar, By Tom Smith (Uniphar)
2025-10-22T14:00:00
Sponsored by Bruker
Site powered by Webvision Cloud